Semnur Pharmaceuticals, Inc. (SMNR)
0.45
-0.01
(-2.17%)
USD |
OTCM |
Sep 18, 16:00
Semnur Pharmaceuticals Free Cash Flow : -10.49M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -10.49M |
| March 31, 2026 | -8.086M |
| December 31, 2025 | -5.814M |
| September 30, 2025 | -3.616M |
| June 30, 2025 | -4.533M |
| March 31, 2025 | -4.916M |
| December 31, 2024 | -4.891M |
| September 30, 2024 | -3.643M |
| Date | Value |
|---|---|
| June 30, 2024 | -0.7233M |
| March 31, 2024 | -0.7665M |
| December 31, 2023 | -0.6328M |
| September 30, 2023 | -0.6396M |
| June 30, 2023 | -0.6056M |
| March 31, 2023 | -0.6665M |
| December 31, 2022 | -0.4261M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Scilex Holding Co. | -61.82M |
| ANI Pharmaceuticals, Inc. | 167.52M |
| Corcept Therapeutics, Inc. | 106.92M |
| Veru, Inc. | -26.04M |
| Johnson & Johnson | 22.61B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.138M |
| Cash from Financing (Quarterly) | 2.074M |
| Free Cash Flow Per Share (Quarterly) | -0.0093 |
| Free Cash Flow to Equity (Quarterly) | -5.507M |
| Free Cash Flow to Firm (Quarterly) | -2.015M |
| Free Cash Flow Yield | -10.45% |